When smoking stops, lungs keep declining; beta-blocker didn’t cut COPD risks

The effect of smoking lingers By Jim Kling   A large cohort study shows increased lung function decline, even long after smoking cessation.   Other news: Beta-blocker treatment did not reduce exacerbation risk in COPD The use of metoprolol did not significantly reduce the median time to first exacerbation in COPD, compared with placebo.   Eating disorders may add to poor type 2 control, but BMI confounds the issue Type 2 diabetes patients with binge eating disorders had worse glycemic control than did those without eating disorders.   Study: Half of college women exhibited binge eating symptoms Binge eating symptoms were noted in 50% of college women and associated with greater depression and anxiety.   Once-daily oral JAK inhibitor for atopic dermatitis effective in phase 3 study Abrocitinib took a step closer to becoming the first once-daily oral Janus kinase 1 inhibitor approved for atopic dermatitis.   You can contact the MDedge Daily Medical News by emailing us at [email protected] or following us on Twitter at @MDedgeTweets.